Literature DB >> 8712096

Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction.

J L Anderson1, L A Karagounis, R M Califf.   

Abstract

Coronary patency has been used as a measure of thrombolysis success after acute myocardial infarction (AMI). The Thrombolysis in Myocardial Infarction (TIMI) study grading scale for coronary perfusion has gained wide acceptance, but the significance of individual grades on clinical outcome has not been adequately tested. We hypothesized that optimal outcomes would be achieved only with early (and maintained) TIMI grade 3 (complete) perfusion compared with TIMI grade 2 (partial perfusion, previously classified as a reperfusion success) or grades 0 or 1 (occluded arteries). Five recent, angiographically controlled, prospectively performed studies of thrombolysis in AMI were identified, representing 3,969 patients. Odds ratios for mortality by early perfusion grades were calculated using the Mantel-Haenszel test and combined in a weighted fashion. Results for selected clinical and laboratory outcomes by patency grade were also assessed. Overall, mortality averaged 8.8% for TIMI grade 0/1, 7.0% for grade 2, and 3.7% for grade 3 perfusion. The odds ratio (OR) for early mortality was substantially reduced for grade 3 versus <3 perfusion (OR = 0.45, confidence interval [CI] 0.34 to 0.61, p <0.0001). In pairwise comparisons, grade 3 was clearly superior to grade 2 (OR = 0.54, CI) 0.37 to 0.78, p = 0.001) as well as grades 0/1 (OR = 0.41, CI 0.30 to 0.56, p <0.0001). Acute and convalescent ejection fraction, regional wall motion, time to enzyme peaks (creatine kinase [CK], creatine kinase myocardial bond [CK-MB]), peak enzyme levels [CK, lactate dehydrogenase [LDH], LDH-1), and risk of heart failure were each significantly less in patients achieving grade 3 than grade 2 (or lower grades) perfusion. Results were observed despite the frequent use of interventions after angiography. This meta-analysis demonstrates that early and complete (grade 3) flow is associated with superior survival and clinical outcome; grade 2 perfusion results in an inferior outcome, closer to that of an occluded than an open artery. The goal of reperfusion strategies should be early and maintained TIMI grade 3 perfusion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712096     DOI: 10.1016/s0002-9149(96)00217-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

Review 1.  Coronary Disease: Acute myocardial infarction: failed thrombolysis.

Authors:  M A de Belder
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

Review 2.  Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: will the combination with thrombolytics become reality?

Authors:  Uwe Zeymer
Journal:  J Thromb Thrombolysis       Date:  2003-04       Impact factor: 2.300

3.  Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.

Authors:  Hidefumi Nakahashi; Masami Kosuge; Kentaro Sakamaki; Masayoshi Kiyokuni; Toshiaki Ebina; Kiyoshi Hibi; Kengo Tsukahara; Noriaki Iwahashi; Shotaro Kuji; Mari S Oba; Satoshi Umemura; Kazuo Kimura
Journal:  Heart Vessels       Date:  2016-04-22       Impact factor: 2.037

Review 4.  Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests.

Authors:  Hernán Mejía-Rentería; Nina van der Hoeven; Tim P van de Hoef; Julius Heemelaar; Nicola Ryan; Amir Lerman; Niels van Royen; Javier Escaned
Journal:  Int J Cardiovasc Imaging       Date:  2017-05-13       Impact factor: 2.357

5.  The never ending quest for an ideal angiographic surrogate of coronary reperfusion.

Authors:  Vijayakumar Subban; Ajit S Mullasari
Journal:  Indian Heart J       Date:  2012-12-26

6.  Therapy in ST-elevation myocardial infarction: reperfusion strategies, pharmacology and stent selection.

Authors:  Vikas Singh; Mauricio G Cohen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-05

Review 7.  Acute myocardial infarction in the obstetric patient.

Authors:  Tabassum Firoz; Laura A Magee
Journal:  Obstet Med       Date:  2012-03-22

8.  Contemporary Trends and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction and End-Stage Renal Disease on Dialysis: Insight from the National Inpatient Sample.

Authors:  Muhammad Zia Khan; Moinuddin Syed; Mohammed Osman; Mohammed Faisaluddin; Samian Sulaiman; Peter D Farjo; Muhammad U Khan; Pratik Agrawal; Anas Alharbi; Safi U Khan; Muhammad Bilal Munir; Sudarshan Balla
Journal:  Cardiovasc Revasc Med       Date:  2020-05-11

Review 9.  Systematic review of fibrinolytic-facilitated percutaneous coronary intervention: potential benefits and future challenges.

Authors:  J Afilalo; A Michael Roy; M J Eisenberg
Journal:  Can J Cardiol       Date:  2009-03       Impact factor: 5.223

10.  Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy.

Authors:  Gjin Ndrepepa; Dritan Keta; Stefanie Schulz; Robert A Byrne; Julinda Mehilli; Jürgen Pache; Melchior Seyfarth; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2009-09-10       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.